These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 321260)

  • 81. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene.
    Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K
    Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Use of blockers and stimulators of prolactin secretion in persistent lactorrhea-amenorrhea syndrome.
    Starkova NT; Mel'nichenko GA
    Neurosci Behav Physiol; 1980; 10(6):476-80. PubMed ID: 6783976
    [No Abstract]   [Full Text] [Related]  

  • 83. Treatment of galactorrhea-amenorrhea.
    De Leon FD
    Am Fam Physician; 1985 Dec; 32(6):121-4. PubMed ID: 4072865
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 85. Pituitary hormonal reserve in patients presenting hyperprolactinemia, intrasellar masses, and amenorrhea without galactorrhea.
    Zarate A; Canales ES; Villalobos H; Soria J; Jacobs LS; Kastin AJ; Schally AV
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1034-7. PubMed ID: 805793
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Galactorrhea and the defective luteal phase of the menstrual cycle.
    el-Mahgoub S
    Int J Gynaecol Obstet; 1978-1979; 16(2):124-7. PubMed ID: 32106
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS].
    Imai T; Yasuda K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):1-15. PubMed ID: 3132404
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of hyperprolactinemic amenorrhea by intermittent administration of bromocryptine (CB 154).
    Polatti E; Bolis PF; Ravagni-Probizer MF; Baruffini A; Cavalleri A
    Am J Obstet Gynecol; 1978 Aug; 131(7):792-6. PubMed ID: 567429
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The natural history of idiopathic hyperprolactinemia.
    Martin TL; Kim M; Malarkey WB
    J Clin Endocrinol Metab; 1985 May; 60(5):855-8. PubMed ID: 3980670
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Amenorrhea following oral contraception.
    Smiljanić N; Ciglar S; Bistricki J
    Acta Obstet Gynecol Scand; 1980; 59(3):261-4. PubMed ID: 6775490
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence.
    Matsuoka I; Nakai T; Miyake M; Hirai M; Ikawa G
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):639-46. PubMed ID: 2885437
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Therapeutic usefulness of bromoergocriptine (CB-154 Sandoz) in patients with galactorrhea (author's transl)].
    González Colindres JA; Canales ES; Levinson G; Zárate A; Sorta J
    Rev Invest Clin; 1975; 27(2):135-8. PubMed ID: 1237173
    [No Abstract]   [Full Text] [Related]  

  • 96. [Dosage of prolactin in normal and pathological subjects (author's transl)].
    Franchimont P; Dourcy C; Legros JJ; Reuter A; Vrindts-Gevaert Y; van Cauwenberge JR; Remacle P; Gaspard U; Colin C
    Ann Endocrinol (Paris); 1976; 37(3):127-56. PubMed ID: 828474
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Primary amenorrhea associated with hyperprolactinemia: four cases with normal sellar architecture and absence of galactorrhea.
    Hughes EG; Garner PR
    Fertil Steril; 1987 Jun; 47(6):1031-2. PubMed ID: 3595894
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hyperprolactinemia with prolonged amenorrhea reversed with bromocriptine in a menopausal woman.
    Goldman M; Steinberger A; Ganti S
    Am J Obstet Gynecol; 1988 Jan; 158(1):117-8. PubMed ID: 3122579
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 100. [13 trisomy born to a mother with galactorrhea-amenorrhea syndrome].
    Imai T; Kamikubo K; Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1714-8. PubMed ID: 3509172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.